The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutic Pipeline Program, 2022Developing Selective Ion Channel Blockers that Reduce Neuroinflammation in Parkinson’s Disease
Study Rationale: We are developing novel therapeutics to reduce brain inflammation and enhance the survival and function of brain cells in Parkinson’s disease (PD). Studies over the past decade have...
-
Spring 2022 RFP: Expanding Biological Understanding of Parkinson's Disease, 2022Assessing Genetic Predisposition to Gastrointestinal Symptoms in Young-onset and Late-onset Parkinson’s Disease
Study Rationale: Constipation is a common, nonmotor manifestation of Parkinson’s disease (PD) that can impact the quality of life of people with the condition. Yet little is known about the genetic...
-
Magnetic Resonance Imaging Biomarkers, 2022Use of Novel Intestinal Imaging for Early Identification of Parkinson’s Disease and Assessment of Response to Therapies that Reduce Alpha-synuclein Accumulation
Study Rationale: Changes in intestinal contractions are a common feature of early Parkinson’s disease (PD). These changes, which often occur before the onset of movement symptoms, are tied to the...
-
Magnetic Resonance Imaging Biomarkers, 2022Dynamic Modeling and Prediction of Parkinsonian Symptom Progression
Study Rationale: Parkinson’s disease (PD) affects different people in different ways. We believe that these differences can offer clues about what happens in the brain before people with PD even begin...
-
Research Grant, 2022Identifying Novel Target Genes and Compounds for Controlling the Motor Symptoms of Parkinson’s Disease
Study Rationale: Understanding neurological conditions has been among the most difficult challenges in modern medicine. The brain contains more than 86 billion nerve cells that form the neural...
-
Summer 2022 RFP: The Edmond J. Safra Movement Disorders Research Career Development Award, 2022Tracking Eye Movements and Pupil Responses as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
Study Rationale: We do not currently have accurate tests to diagnose Parkinson’s disease (PD) and the conditions which mimic it (atypical parkinsonism) at a very early stage. Similarly, we do not have...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.